Aphria Inc. Stock Fires Up on Earnings: 5 Key Takeaways You Need to Know

Aphria Inc.’s (TSX:APH) Q3 earnings send the stock soaring, but were the numbers really that great?

| More on:

Aphria Inc. (TSX:APH) stock is flying through the roof this morning, thanks to yet another blowout quarterly earnings report. A lot has happened between Aphria’s last quarterly earnings release in January and now, and its latest numbers suggest that things are on track for the medical marijuana play.

However, there’s more to the big jump in Aphria’s third-quarter income than meets the eye. Here are five highlights from the earnings report you must know.

100% growth in revenue

Aphria’s Q3 revenue doubled to $10.3 million and jumped 69% for the nine months ended February 28. Three factors propelled Aphria’s sales higher:

  • higher sales volumes
  • higher selling prices
  • contribution from Broken Coast Cannabis, which Aphria acquired during the quarter

The solid growth in Aphria’s third-quarter top-line positions the company for a record year.

Significant decline in cash production cost

Aphria’s production costs are declining rapidly. Aphria’s cash cost to produce per gram of dried cannabis slipped below the $1 mark in Q3. That’s a significant improvement over the $1.73 cash cost per gram that Aphria incurred in the third quarter of 2017.

A sub-$1 cash cost makes Aphria one of the lowest-cost marijuana producers among the publicly listed companies. For perspective, Aurora Cannabis Inc.’s (TSX:ACB) cash cost of production came in at $1.41 per gram during its last reported second quarter.

161% jump in net income, but not from core operations

Aphria earned nearly $13 million in the third quarter compared to only $5 million in the year-ago period.

However, Aphria still incurred an operating loss of around $4 million, as the company is spending heavily on stock-based compensation to reward and retain employees.

That also means that whatever profits the company earned in Q3 were from other sources.

In Q3, Aphria pocketed $26.3 million from a stake sale in Liberty Health Sciences to avoid getting delisted from the TSX after the stock exchange recently flagged concerns about how Canadian marijuana companies with business in the U.S. are violating the U.S. federal marijuana laws.

Share dilution continues

Despite a 161% jump in its net income, Aphria’s earnings per share only doubled to $0.08 during the third quarter. That’s because the company’s outstanding share count is rising steadily thanks to the issue of stocks.

So, for instance, Aphria’s weighted average number of outstanding common shares jumped almost 44% year over year in Q3.

Stock dilution means existing shareholders get a smaller share in the company’s profits.

Expansion plans on track

Last quarter was a particularly busy one for Aphria in terms of growth. Some key moves from the quarter include:

  • acquisition of Broken East Cannabis
  • acquisition of Nuuvera, which is expected to give Aphria a headway into international markets
  • additional investments in Hiku Brands and Althea Company
  • expansion of Aphria One — a 700,000-square-foot Part IV expansion
  • expansion of Aphria Diamona — a 1,300,000-square-foot facility

Both Aphria One and Aphria Diamond are expected to begin marijuana sales by January 2019.

Foolish takeaway: Aphria’s future plans

Aphria’s CEO Vic Neufeld sounded optimistic as he revealed how Aphria is now preparing extensively for the coming legalization of recreational marijuana in Canada, even as it continues to explore “strategic opportunities and partnerships globally.”

It’s clear that Aphria is witnessing strong demand for medical marijuana and positioning itself well for the recreational cannabis market. As for its profitability and share dilution, stay tuned to know what management has to say.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Neha Chamaria has no position in any of the stocks mentioned.

More on Investing

man shops in a drugstore
Dividend Stocks

1 Dividend Stock to Buy if the CRA Tightens TFSA Rules

If there's one thing we all need, it's food. And that's why this dividend stock is a perfect investment.

Read more »

Safety helmets and gloves hang from a rack on a mining site.
Energy Stocks

Suncor Versus Canadian Natural Resources: The Energy Stock I’d Buy on Climbing Oil

These two powerhouse energy stocks deserve attention, so let's get into them.

Read more »

Canada Day fireworks over two Adirondack chairs on the wooden dock in Ontario, Canada
Tech Stocks

Why This Tech Stock Could Be the Next Shopify

This offshoot of Constellation Software is becoming a powerhouse all on its own.

Read more »

space ship model takes off
Dividend Stocks

2 Canadian Stocks That Could Sky Rocket With a Rate Cut

Having trouble sleeping at night over your investments? Then consider these two for a passive income portfolio.

Read more »

Happy golf player walks the course
Dividend Stocks

This 7% Monthly Dividend Stock Could Be Your Secret to Early Retirement

Listen up, you could have an early retirement with this monthly dividend stock, and consistency!

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

This 7.1% Monthly Payer Could Save Any TFSA During Market Chaos

With markets acting out of control, this dividend stock is in a prime position.

Read more »

A meter measures energy use.
Dividend Stocks

Buy the Dip: 1 Utility Stock That’s a Steal After Dropping 22%

This utility stock has had a wild ride, but now might be the time to consider it once again.

Read more »

how to save money
Energy Stocks

BCE: Buy, Sell, or Hold in July 2025?

BCE stock sits 15% below its March peak, but U.S. fibre strategic deals and a de-risked dividend seem appealing at…

Read more »